A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01271
Full Text
Open PDFAbstract
Available in full text
Date
November 22, 2019
Authors
Publisher
Frontiers Media SA